YIH
DSGN icon

Y-Intercept (HK)’s Design Therapeutics DSGN Stock Holding History

Y-Intercept (HK)’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
+12,910
New +$161K ﹤0.01% 1580

Other funds holding DSGN

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Y-Intercept (HK)'s DSGN Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Design Therapeutics (DSGN) in Q2 2026: 12,910 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #1580 among its holdings.

8 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Y-Intercept (HK) held 12,910 shares of Design Therapeutics worth $187K as of Q2 2026.
  • Design Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1580 holding.
  • 8 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.